Chemical Compound
DIHYDROCUCURBITACIN B
CAS Registry Number
13201-14-4
Primary Record
DIHYDROCUCURBITACIN B
Note: Only for scientific research or as raw materials for production.
- In stock
- 8,857 g
- Purity
- 98.1 %
- CAS
- 13201-14-4
Compound Identifiers & Properties
- CAS
- 13201-14-4
- PubChem CID
- 267250
- SMILES
- CC(=O)OC(C)(C)CCC(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O)C)C)C)O)O
- Canonical SMILES
- CC(=O)OC(C)(C)CCC(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C
Names & Synonyms
- DIHYDROCUCURBITACIN B
- 23,24-dihydrocucurbitacin B
- Cucurbitacin B, dihydro-
- 13201-14-4
- ZYL5IKR83R
- RefChem:133776
- AC1L6HT7
- AC1Q5XT1
- CHEBI:62217
- 23,24-dihydro-cucurbitacin B
- CHEMBL553851
- DTXSID701314710
- orb1297396
- NSC-106401
- SCHEMBL29767457
- DTXCID701744640
- KST-1A1095
- C32H48O8
- HY-N4171
- NAA20114
- ZINC4962910
- AR-1A3527
- CID267250
- MFCD21363964
- NSC106401
- AKOS037514506
- ACN-057270
- C32-H48-O8
- EBC-616701
- NSC 106401
- DA-62878
- J40.406C
- MS-30184
- CS-0032304
- NS00094065
- C20787
- DIHYDROCUCURBITACIN B (REFERENCE GRADE)
- G14140
- A1200288
- Q27131690
- (10alpha)-25-(Acetyloxy)-2beta,16alpha,20-trihydroxy-9beta-methyl-19-norlanost-5-ene-3,11,22-trione
- (2S,4R)-2,16beta,20-trihydroxy-9beta,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholest-5-en-25-yl acetate
- (2s,4r,9|A,16|A)-2,16,20-trihydroxy-9,10,14-trimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholest-5-en-25-yl acetate
- [(6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl] acetate
- 25-acetoxy-2beta,16alpha,20-trihydroxy-10alpha-cucurbit-5-ene-3,11,22-trione
- (6R)-6-[(1R,2R,3aS,3bS,8S,9aR,9bR,11aR)-2,8-dihydroxy-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxoheptan-2-yl acetate
- 1322-58-3
- 25-(Acetyloxy)-2beta,16alpha,20-trihydroxycucurbita-5-ene-3,11,22-trione
- 2beta,16alpha,20,25-tetrahydroxy-9-methyl-19-nor-9beta,10alpha-lanost-5-ene-3,11,22-trione, 25-acetate
- 2beta,16alpha,20,25-tetrahydroxy-9-methyl-3,11,22-trioxo-19-nor-9beta,10alpha-lanost-5-en-25-yl acetate
- ((6R)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta(a)phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxoheptan-2-yl) acetate
- (10|A)-25-(Acetyloxy)-2|A,16|A,20-trihydroxy-9|A-methyl-19-norlanost-5-ene-3,11,22-trione
- (10a)-25-(Acetyloxy)-2beta,16a,20-trihydroxy-9beta-methyl-19-norlanost-5-ene-3,11,22-trione
- (2.BETA.,9.BETA.,10.ALPHA.,16.ALPHA.)-25-(ACETYLOXY)-2,16,20-TRIHYDROXY-9-METHYL-19-NORLANOST-5-ENE-3,11,22-TRIONE
- (2S,4R)-2,16alpha,20-Trihydroxy-9alpha,10,14-trimethyl-1,11,22-trioxo-8beta-4,9-cyclo-9,10-secocholest-5-en-25-yl acetate
- [(5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hexyl] acetate
- 19-NORLANOST-5-ENE-3,11,22-TRIONE, 25-(ACETYLOXY)-2,16,20-TRIHYDROXY-9-METHYL-, (2.BETA.,9.BETA.,10.ALPHA.,16.ALPHA.)-
- 19-Norlast-5-ene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-methyl-, (2beta,9beta,10alpha,16alpha)-